Research dossier

Selank — tuftsin analogue dossier

A stabilised analogue of an endogenous immune tetrapeptide.

6 min read · Purpeptide Research Desk ·

Translated from the French original, which remains the reference version: lire en français →

Selank — research dossier illustration

Molecular identity

ParameterValue
CAS number129954-34-3
Molar mass751.88 g/mol
Molecular formulaC₃₃H₅₇N₁₁O₉
Sequence / natureThr-Lys-Pro-Arg-Pro-Gly-Pro
Purity≥99%
AppearanceWhite lyophilised powder

The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.

Research context

Like Semax, this compound illustrates the strategy of stabilising a short endogenous peptide by terminal extension. Its methodological interest lies in the absence of an identified target: it is a case study in the limits of transcriptomic analysis used on its own.

Mechanism studied

Selank is a heptapeptide derived from tuftsin, an endogenous tetrapeptide released by cleavage of the immunoglobulin G heavy chain. As with Semax, the native sequence is extended by Pro-Gly-Pro, which slows its enzymatic degradation.

Published in-vitro work concerns mainly the expression of GABAergic system genes — GABA-A receptor subunits, synthesis enzymes and transporters — measured by transcriptomic analysis on rodent brain tissue and on neuronal cultures.

A second line concerns the activity of the enzymes that degrade enkephalins. Enzymatic assays have measured inhibition of these peptidases in the presence of the compound, the hypothesis proposed being indirect modulation of the availability of endogenous opioid peptides.

Its descent from tuftsin also explains the existence of a parallel body of work on immune parameters in culture.

In-vitro literature

The literature is comparable to that of Semax in both volume and limits: a high proportion of Russian-language publications, and restricted independent replication.

Bibliographic entry points

These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.

Distinguishing this compound from its analogues

Derived from tuftsin, and to be distinguished from it by stability and activity profile. Shares the Pro-Gly-Pro extension with Semax, without functional kinship.

The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.

Methodological limits

Transcriptomic analysis, the dominant method in this literature, reveals expression correlations without establishing mechanistic causality. The absence of a directly identified molecular target limits the design of discriminating experiments.

These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.

Analytical parameters

Heptapeptide de synthèse standard. Aucune contrainte chromatographique particulière.

ParameterValue
StorageStore at −20 °C, protected from light
SolubilitySoluble in bacteriostatic water (BAC)
StabilityStable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C
Control methodsRP-HPLC · MS · NMR

Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.

Resulting concentrations

The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.

Format1 ml2 ml3 ml
10mg10.00 mg/ml5.00 mg/ml3.33 mg/ml
30mg30.00 mg/ml15.00 mg/ml10.00 mg/ml

These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.

Protocol design

Three points govern the validity of an assay using this material, whatever the question being asked.

The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.

The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.

The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.

Lot verification

The following formats are covered by a Janoshik Analytical report, readable from the product page:

  • 10mg — lot report available
  • 30mg — lot report available
FormatLot reportAvailability
10mgCoveredIn stock
30mgCoveredIn stock

The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.

Frequently asked questions

How does this product arrive?

As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.

Which solvent should be used for reconstitution?

Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.

How long does the material remain stable?

The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.

Does the analysis report correspond exactly to my vial?

The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.

Can this product be used on humans or animals?

No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.

See also: Semax or Selank: the comparison

Dossiers in the same category

  • Adamax — CAS N/A (research blend)
  • Semax — CAS 80714-61-0

Related dossiers

All research dossiers → · Catalogue → · Glossary →